ETOP IBCSG Partners Foundation

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

First Posted Date
2004-07-29
Last Posted Date
2013-04-04
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
344
Registration Number
NCT00002784
Locations
🇦🇺

Queen Elizabeth Hospital, Adelaide, South Australia, Australia

🇦🇺

Royal Prince Alfred Hospital, Sydney, Sydney, New South Wales, Australia

🇦🇺

Royal Adelaide Hospital, Adelaide, South Australia, Australia

and more 8 locations

Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer

First Posted Date
2004-07-29
Last Posted Date
2013-04-04
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
452
Registration Number
NCT00002529
Locations
🇨🇭

Universitaetsspital, Zurich, Switzerland

🇦🇺

Royal Prince Alfred Hospital, Sydney, Sydney, New South Wales, Australia

🇦🇺

Royal Adelaide Hospital, Adelaide, South Australia, Australia

and more 17 locations

Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer

First Posted Date
2003-12-11
Last Posted Date
2017-06-16
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
162
Registration Number
NCT00074152
Locations
🇺🇸

Hickman Cancer Center at Bixby Medical Center, Adrian, Michigan, United States

🇺🇸

Kaiser Permanente - Deer Valley, Antioch, California, United States

🇺🇸

Kaiser Permanente Medical Center - Hayward, Hayward, California, United States

and more 195 locations

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases

First Posted Date
2003-11-06
Last Posted Date
2018-01-23
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
931
Registration Number
NCT00072293
Locations
🇮🇹

European Institute of Oncology, Milan, Italy

🇦🇺

Royal North Shore Hospital, St. Leonards, New South Wales, Australia

🇳🇿

Waikato Hospital, Hamilton, New Zealand

and more 28 locations

Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Phase 3
Active, not recruiting
Conditions
Interventions
First Posted Date
2003-08-07
Last Posted Date
2024-01-02
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
2672
Registration Number
NCT00066703
Locations
🇺🇸

Elkhart General Hospital, Elkhart, Indiana, United States

🇺🇸

Memorial Hospital of South Bend, South Bend, Indiana, United States

🇺🇸

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States

and more 225 locations

Premenopausal Endocrine Responsive Chemotherapy Trial

First Posted Date
2003-08-07
Last Posted Date
2016-10-28
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
29
Registration Number
NCT00066807
Locations
🇨🇭

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

🇨🇭

Kantonsspital - St. Gallen, St. Gallen, Switzerland

🇮🇹

Centro di Riferimento Oncologico - Aviano, Aviano, Italy

and more 3 locations

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

First Posted Date
2003-08-07
Last Posted Date
2024-01-02
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
3066
Registration Number
NCT00066690
Locations
🇺🇸

Charlotte Hungerford Hospital Center for Cancer Care, Torrington, Connecticut, United States

🇺🇸

University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

🇺🇸

Finley Hospital, Dubuque, Iowa, United States

and more 492 locations

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer

First Posted Date
2003-01-27
Last Posted Date
2013-04-04
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
473
Registration Number
NCT00002528
Locations
🇦🇺

Royal Prince Alfred Hospital, Sydney, Sydney, New South Wales, Australia

🇦🇺

Sir Charles Gairdner Hospital, Perth, Perth, Western Australia, Australia

🇨🇭

Kantonsspital - St. Gallen, St. Gallen, Switzerland

and more 18 locations

Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Phase 3
Completed
Conditions
Interventions
First Posted Date
2003-01-27
Last Posted Date
2017-12-12
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
8028
Registration Number
NCT00004205
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

🇫🇷

Institut Bergonie, Bordeaux, France

🇨🇭

Kantonsspital - St. Gallen, St. Gallen, Switzerland

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

Phase 3
Completed
Conditions
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-09-16
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
1086
Registration Number
NCT00022516
Locations
🇦🇺

Christchurch Hospital, Christchurch, Australia

🇧🇪

CHU Liege - Domaine Universitaire du Sart Tilman, Liege, Belgium

🇮🇹

Ospedale Sant' Eugenio, Rome, Italy

and more 33 locations
© Copyright 2024. All Rights Reserved by MedPath